Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
This grant funds research focused on understanding the adverse effects of cancer therapies and developing intervention strategies.
About this program
The Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies grant supports research aimed at identifying and characterizing the side effects caused by cancer treatments. This grant is intended for researchers and institutions engaged in clinical trials and studies that explore the mechanisms behind these adverse effects and propose effective intervention strategies. The goal is to improve patient outcomes by mitigating the negative impacts of cancer therapies. Eligible applicants include academic institutions, nonprofit organizations, and other research entities that can conduct clinical trials. The grant encourages innovative approaches to understanding the complexities of cancer treatment side effects and aims to foster collaboration among researchers in the field. By funding this research, the grant seeks to enhance the overall quality of cancer care and improve the quality of life for patients undergoing treatment.
Eligibility
Academic institutions, nonprofit organizations, and research entities conducting clinical trials.